INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Friendshoring: A Strategic Shift In Pharma Supply Chains

  To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.

• Supply Chain Efficiency And Sourcing In Gene Therapy

  An overview of the inbound supply chain in gene therapy and the process development challenges that are frequently faced. Learn about concepts such as scaling, cell culture media sourcing, mixing technologies, and configurable packaging.

• Site Transfer Of Tablet Production From Ex-U.S. To Georgia Site

  Explore how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.

• Top Safety Considerations In Biopharmaceutical Manufacturing

  Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.

• The Future Of RNA Manufacturing Starts With Raw Material Innovation

  2/11/2026

  Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

• Strengthen Pharmaceutical Supply Chains With A U.S.-Based CDMO

  6/5/2025

  While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.

• The Crucial Role Of Cleaning In Effective VPHP Decontamination For Isolators

  12/27/2024

  Effective isolator cleaning is crucial for vapor phase hydrogen peroxide (VPHP) decontamination. Proper tools, techniques, and training ensure sterility, and regulatory compliance.

• Fast-Track Innovation, Address CMC Challenges In Expedited Pathways

  1/26/2026

  Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.

• The Connectivity Crisis Blocking AI Deployment

  6/30/2026

  Disconnected systems and siloed data block analytics in life sciences manufacturing. Learn to bridge the infrastructure gap and build a connected foundation for scalable intelligence.